Integrated Advisors Network LLC Horizon Therapeutics Public LTD CO Transaction History

Integrated Advisors Network LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 02, 2022	SELL	$86.42 - $109.81 $785,039 - $997,514	-9,084 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$98.56 - $119.91 $4,632 - $5,635	47 Added 0.52%	9,084 $979,000
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $83,638 - $100,436	910 Added 11.2%	9,037 $990,000
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $34,668 - $38,559	402 Added 5.2%	8,127 $761,000
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $245,299 - $326,064	3,415 Added 79.23%	7,725 $711,000
Q4 2020 Feb 12, 2021	SELL	$67.0 - $84.39 $10,184 - $12,827	-152 Reduced 3.41%	4,310 $315,000
Q3 2020 Nov 09, 2020	SELL	$55.23 - $79.93 $131,778 - $190,712	-2,386 Reduced 34.84%	4,462 $347,000
Q2 2020 Aug 13, 2020	BUY	$30.2 - $56.98 $206,809 - $390,199	6,848 New	6,848 $381,000
Q1 2020 May 06, 2020	SELL	$24.87 - $38.56 $161,058 - $249,714	-6,476 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$25.43 - $36.67 $164,684 - $237,474	6,476 New	6,476 $234,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Advisors Network LLC with notifications on news.